Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
104.71
-2.74 (-2.55%)
At close: Nov 17, 2026, 4:00 PM EST
105.77
+1.06 (1.01%)
Pre-market: Nov 18, 2026, 4:36 AM EST
Abbott Laboratories Stock Forecast
Stock Price Forecast
According to 28 analysts polled by S&P Global, Abbott Laboratories stock has a consensus rating of "Buy" and an average price target of $118.91. The average 1-year stock price forecast is 13.56% higher than the current stock price, while the lowest is $100 (-4.50%) and the highest is $130 (+24.15%).
Price Target: $118.91 (+13.56%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Abbott Laboratories stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 17 | 16 | 17 | 18 | 18 | 18 |
| Buy | 4 | 4 | 4 | 4 | 5 | 5 |
| Hold | 7 | 7 | 6 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 28 | 27 | 27 | 27 | 28 | 28 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Maintains $115 → $125 | Buy | Maintains | $115 → $125 | +19.38% | Nov 9, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $118 | Buy | Maintains | $118 | +12.69% | Nov 2, 2026 |
| Argus Research | Argus Research | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Oct 27, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $124 → $120 | Buy | Maintains | $124 → $120 | +14.60% | Oct 23, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $120 | Buy | Maintains | $120 | +14.60% | Oct 22, 2026 |
Financial Forecast
Revenue This Year
49.95B
from 44.33B
Increased by 12.67%
Revenue Next Year
53.50B
from 49.95B
Increased by 7.11%
EPS This Year
5.52
from 5.15
Increased by 7.16%
EPS Next Year
5.94
from 5.52
Increased by 7.58%
EPS and Forward PE are based on non-GAAP adjusted numbers.